Pathstone Holdings, LLC Royalty Pharma PLC Transaction History
Pathstone Holdings, LLC
- $22.8 Billion
- Q1 2025
A detailed history of Pathstone Holdings, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Pathstone Holdings, LLC holds 25,021 shares of RPRX stock, worth $832,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,021
Previous 10,041
149.19%
Holding current value
$832,198
Previous $256,000
203.91%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RPRX
# of Institutions
484Shares Held
283MCall Options Held
2.51MPut Options Held
941K-
Morgan Stanley New York, NY41MShares$1.36 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.7MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$766 Million0.01% of portfolio
-
Baillie Gifford & CO13.4MShares$446 Million0.38% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$405 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.5B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...